Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P Poikonen
Leucocyte Nadir as a Marker for Chemotherapy Efficacy in Node-Positive Breast Cancer Treated With Adjuvant CMF
British Journal of Cancer
Cancer Research
Oncology
Related publications
Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides
JAMA Dermatology
Dermatology
Medicine
Randomised Trial: Survival Benefit and Safety of Adjuvant Dose-Dense Chemotherapy for Node-Positive Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
New England Journal of Medicine
Medicine
Subclinical Cardiotoxicity Following Adjuvant Dose-Escalated FEC, High-Dose Chemotherapy, or CMF in Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Adjuvant Chemotherapy Versus Observation After Radical Cystectomy in Patients With Node-Positive Bladder Cancer
Scientific Reports
Multidisciplinary
Adjuvant Chemotherapy for Early Breast Cancer.
BMJ
CAF vs. CMF Combination Chemotherapy in Advanced Breast Cancer Patients
International Journal of Science and Research (IJSR)
Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Adjuvant Chemotherapy for Node Negative, High Recurrence ScoreTM Breast Cancer: In Defense of De-Escalation
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging